Geode Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,969
| Closed | -$325K | – | 4936 |
|
|
2021
Q2 | $325K | Sell |
1,969
-802,718
| -100% | -$134M | ﹤0.01% | 4131 |
|
|
2021
Q1 | $123M | Buy |
804,687
+26,940
| +3% | +$3.66M | 0.02% | 659 |
|
|
2020
Q4 | $97.6M | Buy |
777,747
+43,955
| +6% | +$4.92M | 0.02% | 706 |
|
|
2020
Q3 | $74.4M | Sell |
733,792
-30,139
| -4% | -$3.07M | 0.01% | 716 |
|
|
2020
Q2 | $74.3M | Buy |
763,931
+25,643
| +3% | +$2.39M | 0.02% | 683 |
|
|
2020
Q1 | $61.3M | Buy |
738,288
+20,936
| +3% | +$2.04M | 0.02% | 668 |
|
|
2019
Q4 | $79.7M | Buy |
717,352
+30,111
| +4% | +$3.1M | 0.02% | 700 |
|
|
2019
Q3 | $68.2M | Buy |
687,241
+21,131
| +3% | +$2.1M | 0.02% | 729 |
|
|
2019
Q2 | $66M | Buy |
666,110
+3,768
| +0.6% | +$360K | 0.02% | 742 |
|
|
2019
Q1 | $73M | Buy |
662,342
+20,684
| +3% | +$2.16M | 0.02% | 667 |
|
|
2018
Q4 | $59M | Buy |
641,658
+92,838
| +17% | +$9.39M | 0.02% | 661 |
|
|
2018
Q3 | $60.5M | Buy |
548,820
+63,662
| +13% | +$6.63M | 0.02% | 719 |
|
|
2018
Q2 | $45.3M | Buy |
485,158
+6,264
| +1% | +$539K | 0.01% | 815 |
|
|
2018
Q1 | $39.7M | Buy |
478,894
+4,830
| +1% | +$429K | 0.01% | 842 |
|
|
2017
Q4 | $43.2M | Buy |
474,064
+2,012
| +0.4% | +$167K | 0.01% | 777 |
|
|
2017
Q3 | $36M | Buy |
472,052
+79,191
| +20% | +$5.98M | 0.01% | 853 |
|
|
2017
Q2 | $29.5M | Buy |
392,861
+68,616
| +21% | +$4.76M | 0.01% | 932 |
|
|
2017
Q1 | $21.1M | Buy |
324,245
+18,236
| +6% | +$1.07M | 0.01% | 1102 |
|
|
2016
Q4 | $16.9M | Buy |
306,009
+67,058
| +28% | +$3.68M | 0.01% | 1206 |
|
|
2016
Q3 | $13.5M | Buy |
238,951
+3,552
| +2% | +$174K | 0.01% | 1285 |
|
|
2016
Q2 | $9.83M | Buy |
235,399
+63,403
| +37% | +$2.92M | 0.01% | 1436 |
|
|
2016
Q1 | $7.35K | Buy |
171,996
+18,897
| +12% | +$798K | ﹤0.01% | 1593 |
|
|
2015
Q4 | $6.93M | Buy |
153,099
+16,305
| +12% | +$685K | ﹤0.01% | 1635 |
|
|
2015
Q3 | $5.31M | Buy |
136,794
+9,398
| +7% | +$376K | ﹤0.01% | 1803 |
|
|
2015
Q2 | $4.63M | Buy |
127,396
+6,934
| +6% | +$219K | ﹤0.01% | 1940 |
|
|
2015
Q1 | $3.47M | Buy |
120,462
+18,569
| +18% | +$518K | ﹤0.01% | 2082 |
|
|
2014
Q4 | $2.47M | Buy |
+101,893
| New | +$2.3M | ﹤0.01% | 2294 |
|
Other funds holding PRAH
Geode Capital Management's PRAH Position: Q3 2021 in Review
Geode Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,969 shares — an estimated $325K sold.
Geode Capital Management first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $123M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Geode Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Geode Capital Management sold 1,969 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $325K.
- Geode Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Geode Capital Management's PRA Health Sciences, Inc. position peaked at $123M in Q1 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.